92 related articles for article (PubMed ID: 26226427)
1. A rationally-designed chimeric KDM1A/KDM1B histone demethylase tower domain deletion mutant retaining enzymatic activity.
Burg JM; Makhoul AT; Pemble CW; Link JE; Heller FJ; McCafferty DG
FEBS Lett; 2015 Aug; 589(18):2340-6. PubMed ID: 26226427
[TBL] [Abstract][Full Text] [Related]
2. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
Mao F; Shi YG
Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human histone lysine-specific demethylase 1 (LSD1).
Chen Y; Yang Y; Wang F; Wan K; Yamane K; Zhang Y; Lei M
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13956-61. PubMed ID: 16956976
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of lysine-specific histone demethylase 1A (KDM1A/LSD1) in medial prefrontal cortex facilitates chronic stress-induced pain and emotional dysfunction in female mice.
Wei SQ; Wei JX; Zhao S; Cao DY; Liang L
Neuropharmacology; 2024 Aug; 254():109992. PubMed ID: 38723742
[TBL] [Abstract][Full Text] [Related]
5. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.
Maes T; Mascaró C; Ortega A; Lunardi S; Ciceri F; Somervaille TC; Buesa C
Epigenomics; 2015; 7(4):609-26. PubMed ID: 26111032
[TBL] [Abstract][Full Text] [Related]
6. KDM1 class flavin-dependent protein lysine demethylases.
Burg JM; Link JE; Morgan BS; Heller FJ; Hargrove AE; McCafferty DG
Biopolymers; 2015 Jul; 104(4):213-46. PubMed ID: 25787087
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia.
Jiang Q; Stachelscheid J; Bloehdorn J; Pacholewska A; Aszyk C; Grotenhuijs F; Müller T; Onder O; Wagle P; Herling CD; Kleppe M; Wang Z; Coombes KR; Robrecht S; Dalvi PS; Plosnita B; Mayer P; Abruzzo LV; Altmüller J; Gathof B; Persigehl T; Fischer K; Jebaraj B; Rienhoff HY; Ecker R; Zhao Y; Bruns CJ; Stilgenbauer S; Elenitoba-Johnson K; Hallek M; Schweiger MR; Odenthal M; Vasyutina E; Herling M
Blood; 2023 Jul; 142(1):44-61. PubMed ID: 37023372
[TBL] [Abstract][Full Text] [Related]
8. Targeting the GFI1/1B-CoREST Complex in Acute Myeloid Leukemia.
van Bergen MGJM; van der Reijden BA
Front Oncol; 2019; 9():1027. PubMed ID: 31649884
[TBL] [Abstract][Full Text] [Related]
9. The epigenetically regulated PP1α expression by KDM1A may contribute to oxycodone conditioned place preference in mice.
Li HX; Yang LY; Wan YX; Zhao YP; Liu YF; Wen KS; Yang JJ; Fan XY
Biomed Pharmacother; 2024 Jul; 176():116931. PubMed ID: 38870630
[TBL] [Abstract][Full Text] [Related]
10. Structural insight into substrate recognition by histone demethylase LSD2/KDM1b.
Chen F; Yang H; Dong Z; Fang J; Wang P; Zhu T; Gong W; Fang R; Shi YG; Li Z; Xu Y
Cell Res; 2013 Feb; 23(2):306-9. PubMed ID: 23357850
[No Abstract] [Full Text] [Related]
11. Kdm1a safeguards the topological boundaries of PRC2-repressed genes and prevents aging-related euchromatinization in neurons.
Del Blanco B; Niñerola S; Martín-González AM; Paraíso-Luna J; Kim M; Muñoz-Viana R; Racovac C; Sanchez-Mut JV; Ruan Y; Barco Á
Nat Commun; 2024 Mar; 15(1):1781. PubMed ID: 38453932
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD.
Yang Z; Zhang S; Liu X; Shu R; Shi W; Qu W; Liu D; Cai Z; Wang Y; Cheng X; Liu Y; Zhang XJ; Bai L; Li H; She ZG
J Lipid Res; 2024 Mar; 65(3):100513. PubMed ID: 38295985
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models.
Romussi A; Cappa A; Vianello P; Brambillasca S; Cera MR; Dal Zuffo R; Fagà G; Fattori R; Moretti L; Trifirò P; Villa M; Vultaggio S; Cecatiello V; Pasqualato S; Dondio G; So CWE; Minucci S; Sartori L; Varasi M; Mercurio C
ACS Med Chem Lett; 2020 May; 11(5):754-759. PubMed ID: 32435381
[TBL] [Abstract][Full Text] [Related]
14. Defective heart development in hypomorphic LSD1 mice.
Nicholson TB; Su H; Hevi S; Wang J; Bajko J; Li M; Valdez R; Loureiro J; Cheng X; Li E; Kinzel B; Labow M; Chen T
Cell Res; 2011 Dec; ():. PubMed ID: 22143567
[TBL] [Abstract][Full Text] [Related]
15. Structure of the JmjC domain-containing protein NO66 complexed with ribosomal protein Rpl8.
Wang C; Zhang Q; Hang T; Tao Y; Ma X; Wu M; Zhang X; Zang J
Acta Crystallogr D Biol Crystallogr; 2015 Sep; 71(Pt 9):1955-64. PubMed ID: 26327385
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting of KDM1A and antioxidants is an effective anticancer strategy.
Mudambi S; Fitzgerald ME; Washington DL; Pera PJ; Huss WJ; Paragh G
bioRxiv; 2024 Jun; ():. PubMed ID: 38915482
[TBL] [Abstract][Full Text] [Related]
17. A histone demethylase links the loss of plasticity to nongenetic inheritance and morphological change.
Levis NA; Ragsdale EJ
Nat Commun; 2023 Dec; 14(1):8439. PubMed ID: 38114491
[TBL] [Abstract][Full Text] [Related]
18. UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1.
Choi HJ; Park JH; Park M; Won HY; Joo HS; Lee CH; Lee JY; Kong G
EMBO Rep; 2015 Oct; 16(10):1288-98. PubMed ID: 26303947
[TBL] [Abstract][Full Text] [Related]
19. Hologram quantitative structure-activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors.
Maltarollo VG; Honório KM; Emery FS; Ganesan A; Trossini GH
Future Med Chem; 2015; 7(11):1381-94. PubMed ID: 26230878
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer.
Kosumi K; Baba Y; Sakamoto A; Ishimoto T; Harada K; Nakamura K; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Hino S; Nakao M; Baba H
Int J Cancer; 2016 Jan; 138(2):428-39. PubMed ID: 26240060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
